Back
Vincerx Pharma Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
14
VINC
Vincerx Pharma
Last Price:
0.34
Seasonality Move:
3.02%
Sell
46
NBY
NovaBay Pharmaceuticals
Last Price:
0.74
Seasonality Move:
-14.63%
Sell
14
Vincerx Pharma (VINC)
is a Sell
Is Vincerx Pharma a Buy, Sell or Hold?
- The current Vincerx Pharma [VINC] share price is $0.35. The Score for VINC is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- VINC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.75. The Score for NBY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VINC Stock Price Chart
What is Vincerx Pharma's stock price today?
-
The Vincerx Pharma share price today is $0.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VINC is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.75
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VINC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 27.98 | Sell |
Chaikin Money Flow: | -32452 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.65) | Sell |
Bollinger Bands (100): | (0.51 - 0.77) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 64.79 | Buy |
Chaikin Money Flow: | 1111256 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.59 - 0.71) | Buy |
Bollinger Bands (100): | (0.31 - 1.95) | Sell |
VINC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.37 | Sell |
20-day SMA: | 0.45 | Sell |
50-day SMA: | 0.62 | Sell |
200-day SMA: | 1.57 | Sell |
8-day EMA: | 0.38 | Sell |
20-day EMA: | 0.44 | Sell |
50-day EMA: | 0.56 | Sell |
200-day EMA: | 1.07 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.61 | Buy |
20-day SMA: | 0.64 | Buy |
50-day SMA: | 0.59 | Buy |
200-day SMA: | 2.73 | Sell |
8-day EMA: | 0.63 | Buy |
20-day EMA: | 0.63 | Buy |
50-day EMA: | 0.75 | Buy |
200-day EMA: | 6.47 | Sell |
Vincerx Pharma Earnings Growth & VINC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and a decrease next year of $0.02 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Vincerx Pharma Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |